Myopathy with DPP-4 inhibitors and statins in the real world: investigating the likelihood of drug-drug interactions through the FDA adverse event reporting system.
Ippazio Cosimo AntonazzoElisabetta PoluzziEmanuele ForcesiFrancesco SalvoAntoine ParienteGiulio MarchesiniFabrizio De PontiEmanuel RaschiPublished in: Acta diabetologica (2019)
Real-world FAERS data do not raise concern for muscular toxicity with DPP4-is in combination with statins, making a drug interaction very unlikely.